Joseph M. Palumbo's most recent trade in BioVie Inc was a trade of 15,417 Stock Option (right to buy) done . Disclosure was reported to the exchange on Dec. 20, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BioVie Inc | Joseph M. Palumbo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2024 | 15,417 | 15,417 | - | - | Stock Option (right to buy) | |
| BioVie Inc | Joseph M. Palumbo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| BioVie Inc | Joseph M. Palumbo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 156,000 | 156,000 | - | - | Stock Option (right to buy) | |
| BioVie Inc | Joseph M. Palumbo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 116,000 | 148,196 (2%) | 2% | 0 | Common Stock | |
| BioVie Inc | Joseph M. Palumbo | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.47 per share. | 16 Feb 2023 | 29,000 | 119,196 (2%) | 0% | 0.5 | 13,746 | Common Stock |
| BioVie Inc | Joseph M. Palumbo | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.12 per share. | 16 Feb 2023 | 2,476 | 37,148 (0%) | 0% | 6.1 | 15,153 | COMMON STOCK |
| BioVie Inc | Joseph M. Palumbo | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.51 per share. | 16 Feb 2023 | 2,476 | 34,672 (0%) | 0% | 5.5 | 13,643 | Common Stock |
| BioVie Inc | Joseph M. Palumbo | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.18 per share. | 16 Feb 2023 | 2,476 | 32,196 (0%) | 0% | 1.2 | 2,922 | Common Stock |
| BioVie Inc | Joseph M. Palumbo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Nov 2022 | 39,624 | 39,624 (0%) | 0% | 0 | COMMON STOCK | |
| BioVie Inc | Joseph M. Palumbo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 124,167 | 124,167 | - | - | Stock Option (right to buy) |